Hedge Funds Are Crazy About Idenix Pharmaceuticals Inc (NASDAQ:IDIX)

Idenix Pharmaceuticals Inc (NASDAQ:IDIX)Is Idenix Pharmaceuticals Inc (NASDAQ:IDIX) the right investment to pursue these days? The smart money is in an optimistic mood. The number of long hedge fund bets went up by 1 lately.

In the 21st century investor’s toolkit, there are many metrics investors can use to analyze stocks. A duo of the most innovative are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the elite investment managers can outperform the market by a solid margin (see just how much).

Just as integral, bullish insider trading sentiment is a second way to break down the world of equities. Obviously, there are a number of motivations for an insider to sell shares of his or her company, but only one, very obvious reason why they would behave bullishly. Plenty of empirical studies have demonstrated the market-beating potential of this tactic if you understand where to look (learn more here).

With all of this in mind, we’re going to take a glance at the latest action regarding Idenix Pharmaceuticals Inc (NASDAQ:IDIX).

What does the smart money think about Idenix Pharmaceuticals Inc (NASDAQ:IDIX)?

At the end of the fourth quarter, a total of 17 of the hedge funds we track held long positions in this stock, a change of 6% from the third quarter. With hedgies’ sentiment swirling, there exists a few noteworthy hedge fund managers who were increasing their holdings considerably.

Of the funds we track, Seth Klarman’s Baupost Group had the most valuable position in Idenix Pharmaceuticals Inc (NASDAQ:IDIX), worth close to $100 million, accounting for 3.2% of its total 13F portfolio. Coming in second is Brookside Capital, managed by Bain Capital, which held a $61 million position; the fund has 1.4% of its 13F portfolio invested in the stock. Some other hedgies that are bullish include Roberto Mignone’s Bridger Management, Phill Gross and Robert Atchinson’s Adage Capital Management and Jacob Doft’s Highline Capital Management.

As aggregate interest increased, specific money managers were leading the bulls’ herd. Bridger Management, managed by Roberto Mignone, created the most valuable position in Idenix Pharmaceuticals Inc (NASDAQ:IDIX). Bridger Management had 14 million invested in the company at the end of the quarter. Sander Gerber’s Hudson Bay Capital Management also made a $1 million investment in the stock during the quarter. The other funds with new positions in the stock are Mark Kingdon’s Kingdon Capital and Barton Biggs’s Traxis Partners.

What do corporate executives and insiders think about Idenix Pharmaceuticals Inc (NASDAQ:IDIX)?

Insider trading activity, especially when it’s bullish, is at its handiest when the primary stock in question has seen transactions within the past 180 days. Over the latest six-month time period, Idenix Pharmaceuticals Inc (NASDAQ:IDIX) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

With the returns shown by our strategies, everyday investors should always pay attention to hedge fund and insider trading sentiment, and Idenix Pharmaceuticals Inc (NASDAQ:IDIX) applies perfectly to this mantra.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!